When we began working with our first radiology clients well over 10 years ago, we assumed they would be similar to most other medical and law groups for which we had consulted.

Of all scenarios in radiology that call for lightning-fast turnaround times coupled with absolute accuracy, few present the pressure of serving as the radiology group on call for in-season sports-injury studies.

What do you do with legacy data-storage applications containing near-antique patient information—so old it hasn’t been accessed in up to 20 years—that may yet be needed for legal, financial, clinical or population-management purposes?

Hospital CIOs now recognize that it’s no longer a question of whether vendor neutral archive (VNA) is a technology they should consider, but rather when is the right time to introduce VNA to their IT organization.

It’s T-minus two and a half years, give or take, on the liftoff of Meaningful Use stage 3. In 2018, every eligible hospital and eligible professional must attest to a single set of eight objectives—or suffer reduced Medicare/Medicaid reimbursements—in what is expected to be the final and definitive MU stage.

Every hospital-based radiology department in the U.S. knows it needs to reduce costs while improving care—now, not later on down the road—but only the most focused and forward-looking manage to pull off the feat one day and, the next, secure its sustainability for many years to come.

Why in the world would two radiology practices competing for business in the same market consider sharing market information, revealing operational and performance data and—most counterintuitively of all—combining forces and resources in a joint venture (JV)?

It’s been half a year since RadAnalytics last heard from Scott Luchs, MD, president of Ramapo Radiology Associates in New York State’s Hudson Valley.